FDA Approves Hibsago, the First Drug Offering a ‘Functional Cure’ for Chronic Hepatitis B
The US Food and Drug Administration has approved Hibsago, the first drug to offer what doctors call a “functional cure” for chronic hepatitis B — suppressing the virus to...